Saturday, May 28, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Single-cell genome sequencing provides a new way to think about Alzheimer’s disease

by Medical Finance
in News
First patient-derived stem cell model developed for studying oculocutaneous albinism
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

Alzheimer’s disease is marked by a loss of functional neurons in the brain. But what causes this loss? Through single-cell genome sequencing, researchers at Boston Children’s Hospital, Brigham and Women’s Hospital, and the Broad Institute show that people with Alzheimer’s have an abundance of newly acquired mutations in their neurons -; more than people of the same age without Alzheimer’s, and enough to disable genes important to brain function. Findings were published in Nature on April 20.

Cells have repair pathways to undo DNA damage, but our work shows that in Alzheimer’s disease, neurons can’t keep up with the repairs, so the damage is permanent and cumulative. This work provides a new way of thinking about neurodegenerative diseases such as Alzheimer’s, suggesting that they impair the ability of neurons to use their genome. “


Christopher Walsh, MD, PhD, Chief of Genetics and Genomics, Boston Children’s Hospital and Investigator of the Howard Hughes Medical Institutes, and co-senior investigator on the study

The study may also help connect the dots between loss of neurons and the well-documented accumulation of amyloid-β and tau proteins in Alzheimer’s disease. The pattern of mutations the team found suggests that they are caused by reactive oxygen species (ROS), chemicals that can oxidize and damage DNA. Both amyloid-β and tau can induce the production of ROS, and ROS have been found to be increased in the brains of people with Alzheimer’s.

Miller, Huang and colleagues analyzed single-cell whole-genome sequencing data from 319 neurons from the prefrontal cortex and hippocampus of individuals with Alzheimer’s disease and neurotypical people of similar age. These areas are important in cognitive functioning.

They not only found more mutations in those with Alzheimer’s, but differences in the pattern of mutations compared with normally aging brains. These changes -; switches in certain bases or “letters” that make up DNA -; were of a kind known to be induced by ROS, unlike mutations in normally aging brains. The team also found direct evidence of increased oxidation in the neurons of people with Alzheimer’s.

In addition to amyloid-β and tau, inflammation caused by microglia could also contribute to ROS production, notes August Yue Huang, PhD, an Instructor co-mentored by Walsh and Alice Lee, PhD, and co-first author on the paper with Michael B. Miller, MD, PhD, of Boston Children’s Hospital and Brigham and Women’s Hospital. Microglia are immune cells in the brain that can interact with neurons, and have shown to be abnormally activated in Alzheimer’s.

“Neuroinflammation introduced by microglia might be one cause of oxidative damage to the genome,” Huang says.

The researchers note that genes important to brain function may be especially vulnerable to mutations. Essential genes used by the brain tend to be larger than average, presenting a bigger target that is more likely to be “hit” and disrupted. They are also more often turned on.

“Genes with a higher level of expression in the brain -; and are therefore more likely to have critical functions -; had a higher mutation burden,” says Huang.

Treatment implications?

It’s tempting to speculate that antioxidants could have value in Alzheimer’s, but the researchers want to further investigate how oxidation of the genome occurs and the role that inflammation and immune reactions may play.

“We want to look at other neurodegenerative diseases like frontotemporal dementia, ALS, and chronic traumatic encephalopathy to see whether there’s a limit to the number of mutations in brain that a neuron can tolerate,” says Walsh. “We’ve demonstrated that in Alzheimer’s disease, neurons cannot tolerate widespread oxidation of the genome, which results in permanent damage that can’t be fixed.”

Source:

Boston Children’s Hospital

Journal reference:

Miller, M.B., et al. (2022) Somatic genomic changes in single Alzheimer’s disease neurons. Nature. doi.org/10.1038/s41586-022-04640-1.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Gene replacement therapy could help mend a broken heart, study suggests

by Medical Finance
May 28, 2022
0

How can you mend a broken heart? According to researchers from Japan, in some cases gene replacement therapy just might...

Scientists identify a new switch for controlling motor proteins

Broccoli compound triggers controlled cell death and recycling of cellular components in fission yeast

by Medical Finance
May 28, 2022
0

Broccoli may contain advantages beyond nutrition. A molecule found in broccoli, cabbage and more digests down into DIM, a compound...

Nutritional components hold promise for improving the health and well-being of adults

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

by Medical Finance
May 28, 2022
0

A new research paper was published on the cover of Aging (Aging-US) Volume 14, Issue 9, entitled, "Single-cell transcriptomics reveals...

Study: Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease. Image Credit: SKK Pix / Shutterstock

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

by Medical Finance
May 28, 2022
0

Since the Coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China, it has spread to nearly every country, leading to more...

First patient-derived stem cell model developed for studying oculocutaneous albinism

Scientists identify the role of phospholipid in maintaining epithelial cellular adhesion

by Medical Finance
May 28, 2022
0

Cells have certain proteins that help them adhere to each other while covering body surfaces and organs. Loss of these...

Dexamethasone administration at a late time point could enhance transgene expression

Gene therapy effectively reduces neuropathic pain in mice with spinal cord injuries

by Medical Finance
May 28, 2022
0

An international team of researchers, led by scientists at University of California San Diego School of Medicine, report that a...

Next Post
First patient-derived stem cell model developed for studying oculocutaneous albinism

New training scheme for convolutional neural networks automates cell segmentation and counting

Scientists identify a new switch for controlling motor proteins

Scientists discover how immune proteins defend plants against invading microorganisms

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Pandemic 620x480
    COVID-19 pandemic has widened gender inequities in health
  • New 3D model of living brain cancer overcomes a major challenge in tissue engineering
    New 3D model of living brain cancer overcomes a major challenge in tissue engineering
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply